Poster Session B   |   7:00am Expo - Hall A & C   |   Poster ID #310

Chirality graphene nanoparticles mediated microRNA delivery approach

Program:
Academic Research
Category:
Drug Discovery, Design, and Delivery
FDA Status:
Not Applicable
CPRIT Grant:
Cancer Site(s):
Prostate
Authors:
Eswara NHK Ghali
The University of Texas Rio Grande Valley
Pranav FNU
The University of Texas Rio Grande Valley
Neeraj Chauhan
The University of Texas Rio Grande Valley
Rahul Tiwari
The University of Texas Rio Grande Valley
Subhash C Chauhan
The University of Texas Rio Grande Valley
Murali M Yallapu
The University of Texas Rio Grande Valley

Introduction

Graphene (G) has been established as an exciting prospect for a broad range of applications owing to its remarkable properties. As the molecular structure of G itself is achiral thus introducing chirality in G by simple attachment of a functional group (a chiral ligand) on the G nanosheet may result in more diverse applications. The recent innovations of G chiral nanosystems have been extended to drug delivery. Herein, we have developed a novel and facile synthesis method for producing chiral G for its application in the chirality-dependent microRNA delivery.

Methods

L-graphene and D-graphene were produced in a single step by using chiral L-tyrosine and D-tyrosine as a stabilizing and chiral-inducing agent and applying high-temperature sonication. The chirality of the exfoliated L-graphene and D-graphene was assessed with circular dichroism (CD) spectroscopy and their structural, morphological, and surface evaluations were studied using Raman spectroscopy, transmission electron microscopy (TEM), and X-ray photoelectron spectroscopy (XPS), respectively. In addition, an attempt has been made to explore the cell viability, hemocompatibility, cellular uptake, and internalization pathway, chirality-mediated interaction, and microRNA (hsa-miR-205-5p) transfection with C4-2B prostate cancer cells.

Results

The CD spectra confirmed the chirality present in the exfoliated L(D)-Graphene. Moreover, the Raman spectrum and TEM data confirmed the formation of multi-layer graphene with asymmetric morphology and a large aspect ratio. L-graphene and D-graphene show cellular compatibility. Chiral preferential binding occurring between miR-205 and D-graphene makes them an exciting prospect for gene delivery. D-graphene exhibits superior hemocompatibility compared to commercially available transfection reagent (Lipofectamine). Cellular uptake is clearly shown by internalization of D-graphene into C4-2B prostate cancer cells. miR-205 efficient delivery utilizing D-graphene was confirmed by transfection efficiency and MTT assay.  

Conclusion

Our results demonstrated that a direct approach - one-step liquid phase exfoliation - induced chirality in graphene and their selective chirality-mediated microRNA delivery.